# Revaccination With Influenza Vaccine GSK1247446A

> **NCT00545025** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 243 (actual)

## Conditions studied

- Influenza
- Influenza, Human

## Interventions

- **BIOLOGICAL:** Influenza Vaccine GSK1247446A
- **BIOLOGICAL:** Fluarix™

## Key facts

- **NCT ID:** NCT00545025
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-15
- **Primary completion:** 2007-12-12
- **Final completion:** 2007-12-12
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545025, "Revaccination With Influenza Vaccine GSK1247446A". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT00545025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*